Samuel Altman joins Aveanna (AVAH) board and files initial Form 3
Rhea-AI Filing Summary
Aveanna Healthcare Holdings, Inc. director Samuel Altman has filed an initial Form 3 statement of beneficial ownership. The excerpt lists him as a director of the company and shows no reported buy, sell, or other share transactions in this filing data.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does Aveanna Healthcare (AVAH) disclose in Samuel Altman’s Form 3?
The filing identifies Samuel Altman as a director of Aveanna Healthcare Holdings, Inc. It shows no reported purchases, sales, or other share transactions in the provided Form 3 data.
Does Samuel Altman report any stock transactions in this AVAH Form 3?
No, the summarized data for this Form 3 shows zero buy, sell, acquire, or dispose transactions and no derivative exercises or gifts associated with Samuel Altman.
What insider role does Samuel Altman hold at Aveanna Healthcare (AVAH)?
Samuel Altman is listed as a director of Aveanna Healthcare Holdings, Inc. in this Form 3. He is not flagged as an officer or ten‑percent owner in the provided data.
Are there any derivative securities reported for Samuel Altman on AVAH’s Form 3?
No, the derivative summary in the filing is empty, and the transaction summary shows zero derivative transactions, indicating no listed options or similar instruments in this excerpt.
What does the transaction summary indicate in this AVAH Form 3?
The transaction summary reports zero buys, sells, exercises, gifts, or tax‑withholding events, and a net buy/sell direction labeled neutral for Samuel Altman in this Form 3 data.